H.R. 160, Protect Medical Innovation Act of 2015; issues relating to life sciences research; tax treatment of inverted companies; tax issues in mergers and acquisitions of U.S. firms. Oversight of implementation of the America Invents Act; issues relating to patent settlements; H.R. 9, the Innovation Act; issues relating to the misuse of the inter partes review process. Issues relating to prescription drug abuse; issues relating to incentives for tamper-resistant formulations; issues relating to Medicare Part D rebates; compounding and drug supply chain legislation; H.R. 471, Ensuring Patient Access and Effective Drug Enforcement Act of 2015; issues relating to the labeling of generic drugs; issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; issues related to bioequivalence and related administrative procedures; issues relating to products containing high doses of acetaminophen.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ENDO INTERNATIONAL
1400 Atwater Drive, Malvern, PA, 19355, US
JAMES BRIAN MUNROE ANDREW SCOTT JAMES BRIAN MUNROE ANDREW SCOTT JAMES BRIAN MUNROE ANDREW SCOTT